← Back to Search

ACP Video Intervention for Life-Limiting Illness

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 21 or over

Be older than 18 years old

Must not have

Visually impaired beyond 20/200 corrected

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether increasing patients' knowledge about ACP and hospice care will lead to more patients having these discussions with their caregivers.

Who is the study for?

This trial is for adults over the age of 21 with serious illnesses who are receiving home-based care and have a life expectancy of one year or less, as determined by a specific algorithm. Participants must speak English or any of the other 25 languages available for the video intervention. It's not suitable for those with significant visual impairment or cognitive issues due to psychiatric illness.

What is being tested?

The study is testing whether a home Advance Care Planning (ACP) video can help increase understanding about ACP discussions and hospice care among patients with life-limiting illnesses. The aim is to improve patient knowledge through an educational video intervention.

What are the potential side effects?

Since this trial involves an educational video rather than medication, there are no direct medical side effects associated with it. However, participants may experience emotional or psychological responses to discussing end-of-life care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My vision is worse than 20/200 even with glasses or contacts.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to one year follow-up or death

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to one year follow-up or death

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to one year follow-up or death for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hospice utilization

Secondary study objectives

Hospice length of stay

Patient knowledge about Advance Care Planning

Patient reported confidence in care

+5 more

Other study objectives

Cost of care in the last year of life

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Video interventionExperimental Treatment1 Intervention

In addition to usual care, the intervention will entail having a visit by a trained study clinician to provide access to the ACP video. The study clinician will discuss the content of the video and answer any questions.

Group II: Usual CareActive Control1 Intervention

Usual care entails receiving usual medical care by the home-based care team.

0 / 2Eligibility criteria met